2015 Q4 Form 10-K Financial Statement

#000117184317002017 Filed on April 06, 2017

View on sec.gov

Income Statement

Concept 2015 Q4 2015 2014 Q4
Revenue $3.660M $14.38M $3.760M
YoY Change -2.66% 7.36% 68.61%
Cost Of Revenue $2.280M $9.417M $2.340M
YoY Change -2.56% 2.17% 35.26%
Gross Profit $1.380M $4.963M $1.430M
YoY Change -3.5% 18.79% 186.0%
Gross Profit Margin 37.7% 34.51% 38.03%
Selling, General & Admin $310.0K $1.280M $70.00K
YoY Change 342.86% 341.38% 0.0%
% of Gross Profit 22.46% 25.79% 4.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $230.0K $466.6K $10.00K
YoY Change 2200.0% 1039.37% 0.0%
% of Gross Profit 16.67% 9.4% 0.7%
Operating Expenses $1.250M $13.43M $490.0K
YoY Change 155.1% 20.48% 11.36%
Operating Profit $130.0K $946.9K $940.0K
YoY Change -86.17% -57.82% 1466.67%
Interest Expense $20.00K $80.00K
YoY Change
% of Operating Profit 15.38% 8.45%
Other Income/Expense, Net $10.00K $144.5K $60.00K
YoY Change -83.33% 30.11%
Pretax Income $160.0K $1.091M $990.0K
YoY Change -83.84% -53.68% 1550.0%
Income Tax $0.00 $75.29K -$1.510M
% Of Pretax Income 0.0% 6.9% -152.53%
Net Earnings $160.0K $1.016M $2.500M
YoY Change -93.6% -73.53% 4900.0%
Net Earnings / Revenue 4.37% 7.07% 66.49%
Basic Earnings Per Share $0.14
Diluted Earnings Per Share $13.58K $0.08 $240.2K
COMMON SHARES
Basic Shares Outstanding 12.37M 7.389M 137.2M shares
Diluted Shares Outstanding 11.99M

Balance Sheet

Concept 2015 Q4 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.060M $4.060M $2.800M
YoY Change 45.0% 45.0% -89.46%
Cash & Equivalents $4.060M $4.060M $2.803M
Short-Term Investments
Other Short-Term Assets $57.92M $57.92M $52.32M
YoY Change 10.7% 10.7% 52220.0%
Inventory
Prepaid Expenses $149.1K $129.3K
Receivables $1.135M $1.140M $1.037M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $63.11M $63.11M $56.16M
YoY Change 12.39% 12.38% 106.0%
LONG-TERM ASSETS
Property, Plant & Equipment $3.077M $3.080M $2.706M
YoY Change 13.75% 13.65% 2154.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $202.8K $1.820M $204.1K
YoY Change -0.62% -0.55% 70.09%
Total Long-Term Assets $2.166M $5.250M $2.237M
YoY Change -3.21% 6.28% 728.69%
TOTAL ASSETS
Total Short-Term Assets $63.11M $63.11M $56.16M
Total Long-Term Assets $2.166M $5.250M $2.237M
Total Assets $68.36M $68.36M $61.10M
YoY Change 11.88% 11.88% 121.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $143.2K $140.0K $37.81K
YoY Change 278.7% 250.0% -36.99%
Accrued Expenses $1.329M $1.330M $1.851M
YoY Change -28.22% -28.11% 69.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.24M $59.24M $54.08M
YoY Change 9.55% 9.54% 101.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $59.24M $59.24M $54.08M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $59.24M $59.24M $54.08M
YoY Change 9.54% 9.54% 101.12%
SHAREHOLDERS EQUITY
Retained Earnings -$49.05M -$50.07M
YoY Change -2.03%
Common Stock $185.5K $184.2K
YoY Change 0.74%
Preferred Stock
YoY Change
Treasury Stock (at cost) $286.4K $238.2K
YoY Change 20.25%
Treasury Stock Shares $349.6K $333.0K
Shareholders Equity $9.115M $9.120M $7.024M
YoY Change
Total Liabilities & Shareholders Equity $68.36M $68.36M $61.10M
YoY Change 11.88% 11.88% 121.95%

Cashflow Statement

Concept 2015 Q4 2015 2014 Q4
OPERATING ACTIVITIES
Net Income $160.0K $1.016M $2.500M
YoY Change -93.6% -73.53% 4900.0%
Depreciation, Depletion And Amortization $230.0K $466.6K $10.00K
YoY Change 2200.0% 1039.37% 0.0%
Cash From Operating Activities $4.160M $2.090M -$5.790M
YoY Change -171.85% 4.15% -133.05%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K $785.6K $0.00
YoY Change 2036.33%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$60.00K -$785.6K $0.00
YoY Change 2036.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $48.24K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K -48.24K 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 4.160M 2.090M -5.790M
Cash From Investing Activities -60.00K -785.6K 0.000
Cash From Financing Activities -20.00K -48.24K 0.000
Net Change In Cash 4.080M 1.256M -5.790M
YoY Change -170.47% -36.23% -133.05%
FREE CASH FLOW
Cash From Operating Activities $4.160M $2.090M -$5.790M
Capital Expenditures -$60.00K $785.6K $0.00
Free Cash Flow $4.220M $1.304M -$5.790M
YoY Change -172.88% -33.78% -133.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 pyds Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
914902
CY2016Q4 pyds Assets Current Excluding Restricted Cash
AssetsCurrentExcludingRestrictedCash
49221828
CY2015Q4 pyds Assets Current Excluding Restricted Cash
AssetsCurrentExcludingRestrictedCash
45141340
CY2016 pyds Cancellation Of Stock Based Compensation
CancellationOfStockBasedCompensation
-261208
CY2015 pyds Cancellation Of Stock Based Compensation
CancellationOfStockBasedCompensation
-163936
CY2016 pyds Income Tax Reconciliation Utilization Of Net Operating Loss Carryforwards
IncomeTaxReconciliationUtilizationOfNetOperatingLossCarryforwards
76000
CY2015 pyds Income Tax Reconciliation Utilization Of Net Operating Loss Carryforwards
IncomeTaxReconciliationUtilizationOfNetOperatingLossCarryforwards
-454000
CY2015 pyds Issuance Of Common Stock Restricted Under Deferred Compensation Plan
IssuanceOfCommonStockRestrictedUnderDeferredCompensationPlan
CY2016 pyds Issuance Of Common Stock Restricted Under Deferred Compensation Plan
IssuanceOfCommonStockRestrictedUnderDeferredCompensationPlan
419221
CY2016Q4 pyds Liabilities Current Excluding Restricted Cash
LiabilitiesCurrentExcludingRestrictedCash
44699677
CY2015Q4 pyds Liabilities Current Excluding Restricted Cash
LiabilitiesCurrentExcludingRestrictedCash
41269150
CY2016Q4 pyds Restricted Cash Liability Current
RestrictedCashLiabilityCurrent
15803641
CY2015Q4 pyds Restricted Cash Liability Current
RestrictedCashLiabilityCurrent
17972065
CY2016 pyds Reversal Of Deferred Compensation Amortization
ReversalOfDeferredCompensationAmortization
261208
CY2016Q4 pyds Settlement Processing Assets
SettlementProcessingAssets
43851311
CY2015Q4 pyds Settlement Processing Assets
SettlementProcessingAssets
39797232
CY2016Q4 pyds Settlement Processing Liabilities
SettlementProcessingLiabilities
43851311
CY2015Q4 pyds Settlement Processing Liabilities
SettlementProcessingLiabilities
39797232
CY2015 pyds Stock Issued During Period Value Rounding Due To Reverse Stock Split
StockIssuedDuringPeriodValueRoundingDueToReverseStockSplit
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
145044
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
143180
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
907750
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Type
DocumentType
10-K
CY2016Q2 dei Entity Public Float
EntityPublicFloat
8397238
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1135384
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
38469
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
54077
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
703322
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1328738
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
77415
CY2015Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
23147
CY2016Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
221837
CY2015Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
440232
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2249816
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1511355
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63881365
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64302498
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
151551
CY2016 us-gaap Advertising Expense
AdvertisingExpense
46329
CY2015 us-gaap Advertising Expense
AdvertisingExpense
14178
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1314778
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1275130
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26556
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35033
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
163139
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
29762
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3361276
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
CY2016Q4 us-gaap Assets
Assets
69514686
CY2015Q4 us-gaap Assets
Assets
68356491
CY2016Q4 us-gaap Assets Current
AssetsCurrent
65025469
CY2015Q4 us-gaap Assets Current
AssetsCurrent
63113405
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1994707
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2165665
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12392288
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12379537
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11795939
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12029905
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
181818
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
185533
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">Concentration of Credit Risk: </div>Financial instruments that potentially expose the Company to credit risk consist of cash and cash equivalents, and accounts receivable. The Company is exposed to credit risk on its cash and cash equivalents in the event of default by the financial institutions to the extent of balances in excess of amounts that are insured by the FDIC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">($250,000).</div> Accounts receivables potentially subject the Company to concentrations of credit risk. The Company&#x2019;s customer base operates in a variety of industries and is geographically dispersed; however, the relatively small number of customers increases the risk. The Company closely monitors extensions of credit and credit losses have been provided for in the consolidated financial statements and have been within management's expectations. No customer accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of revenues in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div></div></div></div></div></div></div>
CY2016Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
703322
CY2015Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
1328738
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4059606
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2803455
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4120738
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
61132
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1256151
CY2016Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016 us-gaap Cost Of Services
CostOfServices
8293354
CY2015 us-gaap Cost Of Services
CostOfServices
9417334
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
32668
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
75285
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
32668
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
42916
CY2016Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
4082025
CY2015Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
6031362
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1621000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
1621000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13676000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13500000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
23000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
CY2016Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
313000
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
90000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
279000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
370000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12670000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12339000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
52905
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
49636
CY2016 us-gaap Depreciation
Depreciation
738461
CY2015 us-gaap Depreciation
Depreciation
466606
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
901600
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
496368
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
40200000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
192769
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
112414
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
200808
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y62D
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
202849
CY2016 us-gaap Other General Expense
OtherGeneralExpense
3188407
CY2015 us-gaap Other General Expense
OtherGeneralExpense
2408686
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
99277
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4082025
CY2016 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
32369
CY2016 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
132275
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
132275
CY2015Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
132275
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
172899
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
341816
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5777
CY2015 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1163974
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1091372
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32668
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75285
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65490
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
431755
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
48237
CY2016 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
200000
CY2015 us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
155551
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
785571
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
331000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
93000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-407000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
361000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
32668
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
75285
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
48164
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
32369
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-623552
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-416920
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-227634
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
98174
CY2016 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2041
CY2015 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1263
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7089
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
19860
CY2016 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
97322
CY2015 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
79005
CY2016 us-gaap Interest Paid
InterestPaid
CY2015 us-gaap Interest Paid
InterestPaid
CY2016 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
51700
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11988180
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60503318
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
59241215
CY2016Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
CY2015Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Reported Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseReportedClaimsAmount
450000
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
248868
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4599003
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69514686
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68356491
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-431755
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-48237
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-355551
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-785571
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
848438
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2089959
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-1196642
CY2015 us-gaap Net Income Loss
NetIncomeLoss
1016088
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7838197
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
196599
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
144495
CY2016Q4 us-gaap Notes Receivable Net
NotesReceivableNet
200000
CY2015Q4 us-gaap Notes Receivable Net
NotesReceivableNet
CY2016 us-gaap Operating Expenses
OperatingExpenses
13436931
CY2015 us-gaap Operating Expenses
OperatingExpenses
13433582
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-1360573
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
946877
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
231100
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
28000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
125400
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7838197
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7389177
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
142029
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
149118
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4744326
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4588776
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2494510
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3077421
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
15803641
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
17972065
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50251641
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49054999
CY2016 us-gaap Revenues
Revenues
12076358
CY2015 us-gaap Revenues
Revenues
14380459
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1314778
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1275130
CY2016Q4 us-gaap Share Price
SharePrice
1.85
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11950
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
51700
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
138819
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
399874
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
206
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
9011368
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
9115276
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
7024072
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
596349
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
349632
CY2016Q4 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
246717
CY2016 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
246717
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
718149
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
286394
CY2016Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
431755
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
431705
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
48237
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline; font-style: italic;">Use of Estimates: </div>The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div>
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
172832

Files In Submission

Name View Source Status
0001171843-17-002017-index-headers.html Edgar Link pending
0001171843-17-002017-index.html Edgar Link pending
0001171843-17-002017.txt Edgar Link pending
0001171843-17-002017-xbrl.zip Edgar Link pending
exh_1041.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10k_032917p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pyds-20161231.xml Edgar Link completed
pyds-20161231.xsd Edgar Link pending
pyds-20161231_cal.xml Edgar Link unprocessable
pyds-20161231_def.xml Edgar Link unprocessable
pyds-20161231_lab.xml Edgar Link unprocessable
pyds-20161231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending